CVE-2017-13216

Public Exploit

Description

In ashmem_ioctl of ashmem.c, there is an out-of-bounds write due to insufficient locking when accessing asma. This could lead to a local elevation of privilege enabling code execution as a privileged process with no additional execution privileges needed. User interaction is not needed for exploitation. Product: Android. Versions: Android kernel. Android ID: A-66954097.

Category

7.8
CVSS
Severity: High
CVSS 3.0 •
CVSS 2.0 •
EPSS 0.91% Top 30%
Vendor Advisory android.com
Affected: Google Inc. Android
Published at:
Updated at:

References

Link Tags
http://www.securityfocus.com/bid/102390 vdb entry third party advisory
https://source.android.com/security/bulletin/2018-01-01 vendor advisory
https://www.exploit-db.com/exploits/43464/ exploit vdb entry third party advisory
http://www.securitytracker.com/id/1040106 vdb entry third party advisory

Frequently Asked Questions

What is the severity of CVE-2017-13216?
CVE-2017-13216 has been scored as a high severity vulnerability.
How to fix CVE-2017-13216?
To fix CVE-2017-13216, make sure you are using an up-to-date version of the affected component(s) by checking the vendor release notes. As for now, there are no other specific guidelines available.
Is CVE-2017-13216 being actively exploited in the wild?
It is possible that CVE-2017-13216 is being exploited or will be exploited in a near future based on public information. According to its EPSS score, there is a ~1% probability that this vulnerability will be exploited by malicious actors in the next 30 days.
What software or system is affected by CVE-2017-13216?
CVE-2017-13216 affects Google Inc. Android.
This platform uses data from the NIST NVD, MITRE CVE, MITRE CWE, First.org and CISA KEV but is not endorsed or certified by these entities. CVE is a registred trademark of the MITRE Corporation and the authoritative source of CVE content is MITRE's CVE web site. CWE is a registred trademark of the MITRE Corporation and the authoritative source of CWE content is MITRE's CWE web site.
© 2025 Under My Watch. All Rights Reserved.